Ignite Creation Date:
2024-05-05 @ 11:13 PM
Last Modification Date:
2024-10-26 @ 10:30 AM
Study NCT ID:
NCT01288209
Status:
COMPLETED
Last Update Posted:
2014-01-24
First Post:
2011-02-01
Brief Title:
A Phase III Study of TMC435 in Genotype 1 Hepatitis C-infected Participants Who Failed to Respond to Previous IFN-based Therapy
Sponsor:
Janssen Pharmaceutical KK
Organization:
Janssen Pharmaceutical KK
Organization Data
Organization:
Janssen Pharmaceutical KK
Class:
INDUSTRY
Study ID:
CR017689
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Janssen Pharmaceutical KK
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None